IP Library › Granted Patent US 11,291,200
Granted Patent B2
US 11,291,200 · App. 16/347,429 · Granted Apr 5, 2022

Application of viable cell monitor to cryopreservation of plant cells

Inventors: Meijin Guo (Shanghai, CN); Jiarui Li (Shanghai, CN); Zejian Wang (Shanghai, CN); Yuxia Chen (Shanghai, CN); Yingping Zhuang (Shanghai, CN)
Assignee: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
A01N1/0221G01N27/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,291,200
App. No.
16/347,429
Granted
Apr 5, 2022
Kind
B2
Abstract

The present disclosure relates to the application of a viable cell monitor to the cryopreservation of plant cells. The viable cell monitor is, for the first time, used in a method for rapidly evaluating the effect of cell freezing-preservation. The effect of a cryoprotectant on cell preservation is evaluated through the change in the capacitance of viable cells before and after cell freezing and resuscitation. Viable cell electrodes can provide a quick and accurate characterization of viable cell concentrations. Combining the viable cell capacitance with the detection result of 2,3,4-triphenyl tetrazolium chloride (TTC), a rapid and quantitative evaluation of the effect of a freezing method on cell preservation can be achieved, thus overcoming the low effectiveness and non-quantification of previous cell preservation methods. Compared with traditional methods, the method of the present disclosure can improve the comprehensive score of cell cryopreservation by 5 times or more.

Claims (24)

1. A method for increasing the cell viability of freezing-preserved cells, characterized in that the method comprises:

(1) pre-treating plant cells in a logarithmic growth phase by adding the plant cells to a liquid medium comprising 0.15 to 0.3 M sucrose as a pre-treatment agent; and

(2) adding the plant cells into a cryoprotectant containing medium and carrying out cryopreservation, wherein cryoprotectants are DMSO and sucrose, and a final concentration in the medium is:

DMSO: 8-12% (w/v);

sucrose: 8-12% (w/v).

2. The method of claim 1 , characterized in that step (1) further comprises measuring and recording capacitance A 1 of the pre-treated plant cells;

in step (2), after freezing-preservation, further comprises performing cell resuscitation on the plant cells, and measuring and recording capacitance A 2 by using a viable cell monitor;

a basic capacitance of the plant cells is denoted as A 3 and a cell viability preservation rate is obtained according to equation (I):

Cell viability preservation rate=(A 2 -A 1 )/(A 3 -A 1 ) (I);

a cell viability of the plant cells is evaluated according to the resulting cell viability preservation rate.

3. The method of claim 1 , characterized in that the plant cells are plant cells from Siraitia grosvenorii.

4. The method of claim 1 , characterized in that in step (1), the final concentration of sucrose is 0.18-0.22 M, when the sucrose is used as the pre-treatment agent.

5. The method of claim 1 , characterized in that the pre-treatment is performed for 1 to 46 h; a pre-treatment temperature is 25±2° C.; and the pre-treatment is performed by placing the plant cells on a rotary shaker with a rotary speed of 110±20 rpm for the duration of the pre-treatment.

6. The method of claim 1 , characterized by further comprising, after step (1), separating the pre-treated plant cells; or

in step (2), after adding the cells to the cryoprotectant containing medium, the steps of cryopreservation, including:

(i) cell incubation: incubating for 45±10 min at 0-4° C., on a rotary shaker at 110±20 rpm; and

(ii) preserving at −20±2° C. for 40±10 min before preserving at −80° C.±10° C.

7. The method of claim 1 , characterized in that the medium comprises:

an MS medium, 30±5 g/L sucrose, 1.0±0.2 mg/L 6-benzylaminopurine (6-BA), and 0.5±0.1 mg/L naphthylacetic acid (NAA)+100±10 mg/L inositol.

8. The method of claim 1 , wherein the plant cells are callus cells from Siraitia grosvenorii.

9. The method of claim 1 , wherein, in step (1), the final concentration of sucrose is 0.2 M, when the sucrose is used as a pre-treatment agent.

10. The method of claim 1 , wherein the pre-treatment is performed for 5 to 22 hours.

11. The method of claim 1 , wherein the pre-treatment is performed for 8-10 hours.

12. The method of claim 6 , comprising separating the pre-treated cells by centrifugation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2020
From: GUO, MEIJIN; LI, JIARUI; WANG, ZEJIAN; CHEN, YUXIA; ZHUANG, YINGPING
To: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
Reel/Frame 052690/0257 →
Priority Claims (1)
CN 201611041562.6 · Nov 22, 2016 · national
Continuity (1)
Related Publication 20190274299A1 · Sep 12, 2019
Cited By (1)
US 12,669,455